Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Neuroendocrine Tumors 50Pancreatic Neoplasms 6Gastrointestinal Neoplasms 6Stomach Neoplasms 5Carcinoma, Hepatocellular 5Colorectal Neoplasms 4Rectal Neuroendocrine Tumor 3Prostatic Neoplasms 3Neoplasm Metastasis 3Liver Neoplasms 3Esophageal Neoplasms 3Cholangiocarcinoma 3Thyroid Neoplasms 2Rectal Neoplasms 2Neoplasms 2Gastrointestinal Stromal Tumors 2Gastro-enteropancreatic neuroendocrine tumor 2Colonic Neoplasms 2Carcinoma, Neuroendocrine 2Carcinoma 2Carcinoid Tumor 2Biliary Tract Neoplasms 2Appendiceal Neoplasms 2Anus Neoplasms 2Visceral Pain 1Serotonin Syndrome 1Recurrence 1Rectal Neuroendocrine Tumors 1Pheochromocytoma 1Patients With Gastroenteropancreatic Neuroendocrine Tumors 1

Interventions

Endoscopic Mucosal Resection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Rectal Neuroendocrine Tumors × NET × Clear all
NCT07373015 2026-01-28

Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase NA Not yet recruiting
118 enrolled
EndocrineGastrointestinalNET

Rectal Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡